• RNA Splicing Analytics

    + Artificial Intelligence

    for Drug Discovery

  • Cancer and genetic diseases

    affect more than 30 million people a year

    Our mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence.

    15%

    of all disease causing mutations are predicted to disrupt RNA splicing

    370

    known genetic disorders in publications are caused by RNA splicing errors

    50%

    of synonymous cancer-driver mutations impair RNA splicing

  • Artificial Intelligence Platform for Drug Discovery

  • Investors

  • Partners